Related Experiment Video
Updated: Jul 19, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
Published on: June 4, 2012
Epileptogenic activity of methicillin-resistant Staphylococcus aureus (MRSA) antibiotics in rats
Ashequr Rahman1, Jun Ago, Naotaka Matsumoto
1Department of Medicinal Pharmacology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Tsushima-naka, Okayama, Japan.
Abstract:
The present study was undertaken to clarify the epileptogenic activity induced by intracerebroventricular injection (i.c.v.) of antibiotics effective in methicillin-resistant Staphylococcus aureus (MRSA) in chronically electrode implanted rats. Teicoplanin (10-100 microg, i.c.v.) caused dose-related electroencephalographic (EEG) seizure characterized by an uninterrupted high voltage and wave complex. At the same time, the rats showed forelimb clonus, head nodding, jumping and severe convulsion. At a high dose (100 microg, i.c.v.), the drug caused a severe twisting immediately after the intracerebroventricular injection (i.c.v.) followed by jumping and violent convulsion with a continuous rhythmic spike and wave complex in EEG. On the other hand, vancomycin (30-1000 microg, i.c.v.) caused no or almost no epileptogenic activity in terms of behavior and in EEG. However, at a high dose (1000 microg, i.c.v.), the drug caused an occasional spike from the hippocampus without showing any behavioral changes in the rats. Fosfomycin (30-1000 microg, i.c.v.), cefazolin (10-100 microg, i.c.v.) and penicillin G (30-300 microg, i.c.v.), used as reference drugs, caused dose-dependent epileptogenic activity in both EEG. From these findings, it was found that teicoplanin caused a potent epileptogenic activity, different to vancomycin. Therefore, it can be concluded that vancomycin may be safety on epileptogenic activity used for the clinical purpose of infections caused by MRSA.
Insights
Teicoplanin induced dose-related seizures in rats, while vancomycin showed minimal epileptogenic activity. This suggests vancomycin is safer for treating methicillin-resistant Staphylococcus aureus (MRSA) infections.
Area of Science:
- Neuropharmacology
- Infectious Diseases
Background:
- Antibiotics are crucial for treating infections, but their central nervous system (CNS) effects require careful evaluation.
- Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant treatment challenge, necessitating effective antibiotic options.
Purpose of the Study:
- To investigate the epileptogenic potential of antibiotics used against MRSA.
- To compare the CNS effects of teicoplanin and vancomycin following intracerebroventricular administration.
Main Methods:
- Rats with chronic electrodes received intracerebroventricular (i.c.v.) injections of various antibiotics.
- Electroencephalographic (EEG) recordings and behavioral observations were used to assess epileptogenic activity.
- Dose-response relationships for teicoplanin, vancomycin, fosfomycin, cefazolin, and penicillin G were evaluated.
Main Results:
- Teicoplanin induced dose-dependent EEG seizures and convulsions.
- Vancomycin exhibited minimal to no epileptogenic activity, even at high doses.
- Reference antibiotics like fosfomycin, cefazolin, and penicillin G also showed dose-dependent epileptogenic effects.
Conclusions:
- Teicoplanin possesses potent epileptogenic activity, distinct from vancomycin.
- Vancomycin appears to be safe concerning epileptogenic activity for clinical use in MRSA infections.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
